Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Trump’s EPA wants to roll back Biden-era pollution limits for medical device sterilization
Ethylene oxide is an odorless gas used to sterilize pacemakers, leads, stents and many other medical devices. Long-term exposure, however, can cause cancer. The Biden administration made it a priority to reduce ethylene oxide emissions, but many critics thought those cuts were too extreme.
New obesity statistics highlight importance of preventive cardiology
Cardiovascular health is much worse in some parts of the United States than others. Cardiologists in those high-risk areas can make a world of difference by embracing preventive cardiology and working to treat patients before it is too late.
Imaging evaluations and PCI planning: Heartflow announces ‘tremendous progress’ for AI portfolio
Heartflow's AI technologies are at the center of multiple ACC.26 presentations. In addition, the company announced, the first patient was enrolled into the NAVIGATE-PCI registry.
Heart failure hospitalizations after PCI: a warning sign of ‘exceptionally high risk’
Nonfatal adverse events after PCI are associated with an increased risk of two-year mortality. That risk is especially high, it seems, when patients are hospitalized for heart failure symptoms such as shortness of breath and edema.
FDA announces recall of insulin delivery pods
Small tears were found on the inside of some of Insulet Corporation's Omnipod 5 pods. The issue was linked to a total of 18 serious adverse events.

Boston Scientific to acquire Penumbra for $14.5B

This is a cash and stock transaction that values Penumbra at $374 per share. The move helps Boston Scientific expand its vascular and neurovascular portfolios, gaining new treatments for pulmonary embolism, stroke, deep vein thrombosis and many other critical cardiovascular conditions.

cardiologist patient heart compensation starting salary 2022 interventional cardiologist

TAVR’s next big challenge: Providing consistent relief for heart patients with aortic regurgitation

TAVR has already transformed care for patients with severe aortic stenosis. Will it make a similar impact on the treatment of aortic regurgitation?

Novel theranostic shows promise for treating gastric and pancreatic cancer

New theranostic could potentially cure difficult-to-treat gastric and pancreatic cancers

Researchers believe new research findings relating to the PET technique signal its potential “to meaningfully change patient care.”

Google rolls out 2 new open access AI models aimed at medical imaging

The tech giant is making each model publicly available so that researchers and developers can have access to the updated technology.

ASNC reports shortage of cardiac amyloidosis radiotracers

The two vendors involved say supplies of PYP and HDP could be disrupted for months.

Low-volume operators linked to worse outcomes after TAVR, M-TEER

Researchers tracked data from more than 400,00 patients, sharing their findings in JAMA Cardiology.

FDA clears MRI-compatible EP mapping catheter

This represents the first FDA clearance for Imricor Medical Systems. "It’s an exciting achievement and a date to be noted and remembered," CEO Steve Wedan said in a statement.

Boston Scientific Farapoint pulsed field ablation (PFA) catheter

FDA approves Boston Scientific’s Farapoint PFA catheter

The newest addition to the company's Farapulse PFA Platform was specifically approved to perform cavotricuspid isthmus ablation.

Clinical

Trump’s EPA wants to roll back Biden-era pollution limits for medical device sterilization

New obesity statistics highlight importance of preventive cardiology

Imaging evaluations and PCI planning: Heartflow announces ‘tremendous progress’ for AI portfolio

Heart failure hospitalizations after PCI: a warning sign of ‘exceptionally high risk’

FDA announces recall of insulin delivery pods